Hormone therapy bioethics debate
Thu, Mar 25, 2027 · Week 10 · Human Anatomy & Physiology (Human Body Systems)
Today's goal: Students will argue whether minors should access growth-hormone or hormone therapies based on medical and ethical criteria.
What a finished product looks like
This is a model of the work you should turn in today. Use it to check your own: match the structure and the level of detail, do not copy it. Your data and wording should be your own.
Parallel case (not today's question): Should a 14-year-old with type 1 diabetes be allowed to carry an insulin pump and dose their own insulin during the school day without a nurse pressing the button each time?\n\nClaim: I argue that a trained 14-year-old with type 1 diabetes should be allowed to self-dose insulin at school through their own pump, with a documented care plan and school-nurse oversight in place, because prompt insulin delivery keeps blood glucose in a safe range, though the genuine tradeoff is that handing dosing control to a minor also raises the risk of a mistimed or miscalculated dose that could cause dangerous low blood sugar.\n\nEvidence: Insulin is the hormone that lets body cells take up glucose from the blood for energy, and people with type 1 diabetes make little or none of it, so they must add insulin from outside to keep blood glucose from climbing too high. Blood glucose can shift quickly after meals or activity, and waiting for a single nurse to reach every student before every dose can delay treatment. Students who are trained to count carbohydrates and match their dose can respond in minutes rather than waiting in line.\n\nReasoning: The medical benefit is real because timely, correctly sized insulin doses prevent both short-term symptoms and long-term damage from high blood glucose, and a student on site can act faster than a stretched-thin nurse. At the same time, a minor is still developing judgment and can miscount carbohydrates, dose twice by mistake, or ignore a warning, and too much insulin can drop blood sugar to a dangerous low. Because both the benefit and the risk are genuine, the reasonable position is not all-or-nothing control but supervised autonomy: the student doses, but only after documented training, a written care plan, and a nurse available for backup. This respects the patient's growing independence while keeping an adult safeguard in place.\n\nMedical fact cited: insulin is a hormone that regulates blood glucose by helping body cells absorb glucose for energy.\nTradeoff named: the medical benefit of fast, well-matched insulin dosing versus the safety risk of letting a minor control a dose that, if wrong, can cause dangerous low blood sugar.
Also due today: Submit your exit-ticket sentence to the Schoology assignment for HBS Endocrine Day 1.
WebXam problem for today's skill
One exam-style question that uses exactly what you practiced today. Try it before you reveal the answer, then read why each choice is right or wrong.
Tap an answer to see the full explanation. Nothing is recorded or graded.

